FBR Capital Reiterates an 'Outperform' on Colony Financial (CLNY); Increasing Opportunities for the Opportunistic
Get Alerts CLNY Hot Sheet
Price: $8.50 --0%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Join SI Premium – FREE
FBR Capital reiterates an 'Outperform' on Colony Financial, Inc. (NYSE: CLNY), PT $24.
FBR analyst says, "We reiterate our Outperform rating on CLNY shares as: (1) we are enthused about Colony's prospects for portfolio growth, especially pertaining to retaining high-yielding subordinate interests in loan originations, which should push on the forward dividend; and (2) we continue to believe that there is considerable upside in Colony's underlying portfolio. We believe the company's "hybrid" approach between current yield and "back-end loaded" return offers attractive, and differentiated, total return potential for shareholders."
For more ratings news on Colony Financial, Inc. click here and for the rating history of Colony Financial, Inc. click here.
Shares of Colony Financial, Inc. closed at $18.49 yesterday.
FBR analyst says, "We reiterate our Outperform rating on CLNY shares as: (1) we are enthused about Colony's prospects for portfolio growth, especially pertaining to retaining high-yielding subordinate interests in loan originations, which should push on the forward dividend; and (2) we continue to believe that there is considerable upside in Colony's underlying portfolio. We believe the company's "hybrid" approach between current yield and "back-end loaded" return offers attractive, and differentiated, total return potential for shareholders."
For more ratings news on Colony Financial, Inc. click here and for the rating history of Colony Financial, Inc. click here.
Shares of Colony Financial, Inc. closed at $18.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades UBS AG (UBSG:SW) (UBS) to Neutral
- Stifel: Instacart (CART) Under Pressure After Amazon (AMZN) Announces Unlimited Grocery Delivery Subscription
- BMO Capital Reiterates Outperform Rating on Beam Therapeutics Inc (BEAM)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!